These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 110893

  • 1. Molecular heterogeneity of Hageman trait (factor XII deficiency): evidence that two of 49 subjects are cross-reacting material positive (CRM+).
    Saito H, Scott JG, Movat HZ, Scialla SJ.
    J Lab Clin Med; 1979 Aug; 94(2):256-65. PubMed ID: 110893
    [Abstract] [Full Text] [Related]

  • 2. Heterogeneity of human prekallikrein deficiency (Fletcher trait): evidence that five of 18 cases are positive for cross-reacting material.
    Saito H, Goodnough LT, Soria J, Soria C, Aznar J, España F.
    N Engl J Med; 1981 Oct 15; 305(16):910-4. PubMed ID: 6792540
    [Abstract] [Full Text] [Related]

  • 3. [The genetics of factor XII deficiency].
    Kempter B, Rüth S, Epple I, Lohse P.
    Beitr Infusionsther; 1993 Oct 15; 31():174-8. PubMed ID: 7693250
    [Abstract] [Full Text] [Related]

  • 4. Isolation and properties of an abnormal Hageman factor (Factor XII) molecule in a cross-reacting material-positive hageman trait plasma.
    Saito H, Scialla SJ.
    J Clin Invest; 1981 Oct 15; 68(4):1028-35. PubMed ID: 6793628
    [Abstract] [Full Text] [Related]

  • 5. Relationship between kallikrein release and factor XII in normal persons and carriers of the Hageman trait.
    Torres M, Ercoreca L, Lucia JF, Giralt M, Raichs A.
    Thromb Haemost; 1979 Dec 21; 42(4):1286-8. PubMed ID: 261563
    [Abstract] [Full Text] [Related]

  • 6. Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems.
    Saito H, Ratnoff OD.
    J Lab Clin Med; 1975 Mar 21; 85(3):405-15. PubMed ID: 234996
    [Abstract] [Full Text] [Related]

  • 7. Characterization of factor XII Tenri, a rare CRM-negative factor XII deficiency.
    Fujihara N, Tozuka M, Yamauchi K, Ueno I, Urasawa N, Ishikawa S, Hirota-Kawadobora M, Okumura N, Hidaka H, Katsuyama T.
    Ann Clin Lab Sci; 2004 Mar 21; 34(2):218-25. PubMed ID: 15228238
    [Abstract] [Full Text] [Related]

  • 8. Radioimmunoassay of human Hageman factor (factor XII).
    Saito H, Ratnoff OD, Pensky J.
    J Lab Clin Med; 1976 Sep 21; 88(3):506-14. PubMed ID: 956701
    [Abstract] [Full Text] [Related]

  • 9. Functional characterization of a variant factor XII (F XII Locarno) in a cross reacting material positive F XII deficient plasma.
    Wuillemin WA, Furlan M, Stricker H, Lämmle B.
    Thromb Haemost; 1992 Feb 03; 67(2):219-25. PubMed ID: 1621242
    [Abstract] [Full Text] [Related]

  • 10. Immunoquantitation of Hageman factor in urine and plasma of children with nephrotic syndrome.
    Hruby MA, Honig GR, Shapira E.
    J Lab Clin Med; 1980 Sep 03; 96(3):501-10. PubMed ID: 6772722
    [Abstract] [Full Text] [Related]

  • 11. Genetic study in patients with factor XII deficiency: a report of three new mutations exon 13 (Q501STOP), exon 14 (P547L) and -13C>T promoter region in three compound heterozygotes.
    Lombardi AM, Bortoletto E, Scarparo P, Scapin M, Santarossa L, Girolami A.
    Blood Coagul Fibrinolysis; 2008 Oct 03; 19(7):639-43. PubMed ID: 18832903
    [Abstract] [Full Text] [Related]

  • 12. Thromboembolism and bleeding tendency in congenital factor XII deficiency--a study on 74 subjects from 14 Swiss families.
    Lämmle B, Wuillemin WA, Huber I, Krauskopf M, Zürcher C, Pflugshaupt R, Furlan M.
    Thromb Haemost; 1991 Feb 12; 65(2):117-21. PubMed ID: 1905067
    [Abstract] [Full Text] [Related]

  • 13. Urinary excretion of Hageman factor (factor XII) and the presence of nonfunctional Hageman factor in the nephrotic syndrome.
    Saito H, Goodnough LT, Makker SP, Kallen RJ.
    Am J Med; 1981 Mar 12; 70(3):531-4. PubMed ID: 7211894
    [Abstract] [Full Text] [Related]

  • 14. Factor XII Osaka: abnormal factor XII with partially defective prekallikrein cleavage activity.
    Iijima K, Arakawa Y, Sugahara Y, Matsushita M, Moriguchi Y, Shimohiro H, Nakagawa M.
    Thromb Haemost; 2011 Mar 12; 105(3):473-8. PubMed ID: 21264442
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of the activation of Hageman factor (factor XII) by platelet factor 4.
    Dumenco LL, Everson B, Culp LA, Ratnoff OD.
    J Lab Clin Med; 1988 Sep 12; 112(3):394-400. PubMed ID: 3045234
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
    Weiss AS, Gallin JI, Kaplan AP.
    J Clin Invest; 1974 Feb 12; 53(2):622-33. PubMed ID: 11344577
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.